Galmed Pharmaceuticals (GLMD) Cash from Operations (2013 - 2025)

Galmed Pharmaceuticals' Cash from Operations history runs 13 years deep, the most recent figure standing at 1945000.0 for Q4 2025.

• In Q4 2025, Cash from Operations fell 1.94% year-over-year to 1945000.0; the TTM figure through Dec 2025 stood at 6315000.0 (down 7.4% YoY), while the FY2025 annual figure was 6315000.0, down 7.4% from the prior year.
• Cash from Operations was 1945000.0 for Q4 2025 at Galmed Pharmaceuticals, down from 1935000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 256000.0 in Q1 2022 to a low of 11107000.0 in Q2 2022.
• Historically, Cash from Operations has averaged 3486250.0 across 5 years, with a median of 1921500.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations jumped 97.24% in 2022, then slumped 562.11% in 2023.
• A 5-year view of Cash from Operations shows it stood at 6990000.0 in 2021, then soared by 42.43% to 4024000.0 in 2022, then soared by 77.68% to 898000.0 in 2023, then sank by 112.47% to 1908000.0 in 2024, then fell by 1.94% to 1945000.0 in 2025.
• The last three Cash from Operations figures came in at 1945000.0 (Q4 2025), 1935000.0 (Q3 2025), and 1268000.0 (Q2 2025), per Business Quant data.